Chemomab Therapeutics (CMMB) Shareholder's Equity (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.82% |
| Sep 30, 2025 | 15.80% |
| Jun 30, 2025 | -6.68% |
| Mar 31, 2025 | -23.23% |
| Dec 31, 2024 | -17.04% |
| Sep 30, 2024 | 63.43% |
| Jun 30, 2024 | -25.10% |
| Mar 31, 2024 | -21.57% |
| Dec 31, 2023 | -5.80% |
| Sep 30, 2023 | -17.95% |
| Jun 30, 2023 | -21.33% |
| Mar 31, 2023 | -22.83% |
| Dec 31, 2022 | -18.83% |
| Sep 30, 2022 | -13.91% |
| Jun 30, 2022 | -9.43% |
| Mar 31, 2022 | -6.88% |
| Dec 31, 2021 | -6.18% |
| Sep 30, 2021 | -3.71% |
| Jun 30, 2021 | 23.34% |
| Mar 31, 2021 | 410.68% |
| Dec 31, 2020 | -11.15% |
| Sep 30, 2020 | -4.99% |
| Jun 30, 2020 | 19.32% |
| Mar 31, 2020 | -13.33% |
| Dec 31, 2019 | 110.65% |
| Sep 30, 2019 | -526.16% |
| Jun 30, 2019 | -13.06% |
| Mar 31, 2019 | 219.65% |
| Dec 31, 2018 | 113.19% |
| Sep 30, 2018 | -3.67% |